Novo Nordisk A/S (NYSE:NVO) has entered a strategic partnership with Amazon Web Services to accelerate drug discovery and modernize its operations through artificial intelligence and cloud technology. The agreement establishes AWS as Novo Nordisk’s preferred cloud provider and strategic AI partner. The companies have also created a co-innovation hub in London, where AWS engineers and [...]
Novo Nordisk Expands Its AI Push With AWS, But Can It Accelerate Drug Discovery?
